Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum

Tissue Engineering - Part C: Methods

Volumn 14, Issue 3, 2008, Pages 185-196

  Schallmoser, Katharina ^a   Rohde, Eva ^a   Reinisch, Andreas ^a   Bartmann, Christina ^a   Thaler, Daniela ^a   Drexler, Camilla ^a   Obenauf, Anna C ^a   Lanzer, Gerhard ^a   Linkesch, Werner ^a   Strunk, Dirk ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE;

BONE MARROW; CELLULAR THERAPY; MESENCHYMAL STEM CELLS; TISSUE REGENERATION;

CELLS;

ENDOTOXIN; GLUTAMINE; HEPARIN;

ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL LYSATE; CELL SEPARATION; CELL THERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SERUM; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALIA; BOVINAE;

EID: 51449124598     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2008.0060     Document Type: Article

References (52)

1. Caplan, A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11, 1198, 2005.
2. Tykocinski, M.L., Kaplan, D.R., and Medof, M.E. Antigen-presenting cell engineering: the molecular toolbox. Am J Pathol 148, 1, 1996.
3. Dennis, J.E., Cohen, N., Goldberg, V.M., and Caplan, A.I. Targeted delivery of progenitor cells for cartilage repair. J Orthop Res 22, 735, 2004.
4. Sackstein, R., Merzaban, J.S., Cain, D.W., Dagia, N.M., Spencer, J.A., Lin, C.P., and Wohlgemuth, R. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14, 181, 2008.
5. Caplan, A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341, 2007.
6. Fibbe, W.E., and Noort, W.A. Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann N Y Acad Sci 996, 235, 2003.
7. Luria, E.A., Panasyuk, A.F., and Friedenstein, A.Y. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11, 345, 1971.
8. Friedenstein, A.J., Deriglasova, U.F., Kulagina, N.N., Panasuk, A.F., Rudakowa, S.F., Luria, E.A., and Ruadkow, I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2, 83, 1974.
9. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71, 1997.
10. Vilquin, J.T., and Rosset, P. Mesenchymal stem cells in bone and cartilage repair: current status. Regen Med 1, 589, 2006.
11. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., Schoen, F.J., Toner, M., Mooney, D., Atala, A., van Dyke, M.E., Kaplan, D., and Vunjak-Novakovic, G. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
12. Atala, A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 1, 83, 2007.
13. Prockop, D.J., Gregory, C.A., and Spees, J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 100 Suppl 1, 11917, 2003.
14. Dazzi, F., Ramasamy, R., Glennie, S., Jones, S.P., and Roberts, I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev 20, 161, 2006.
15. Locatelli, F., Maccario, R., and Frassoni, F. Mesenchymal stromal cells, from indifferent spectators to principal actors: are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica 92, 872, 2007.
16. Delorme, B., Chateauvieux, S., and Charbord, P. The concept of mesenchymal stem cells. Regen Med 1, 497, 2006.
17. Studeny, M., Marini, F.C., Champlin, R.E., Zompetta, C., Fidler, I.J., and Andreeff, M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62, 3603, 2002.
18. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166, 585, 1996.
19. Bartmann, C., Rohde, E., Schallmoser, K., Purstner, P., Lanzer, G., Linkesch, W., and Strunk, D. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47, 1426, 2007.
20. Wagner, W., Roderburg, C., Wein, F., Diehlmann, A., Frankhauser, M., Schubert, R., Eckstein, V., and Ho, A.D. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25, 2638, 2007.
21. Lazarus, H.M., Haynesworth, S.E., Gerson, S.L., Rosenthal, N.S., and Caplan, A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16, 557, 1995.
22. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
23. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W., Gordon, P.L., Neel, M., Sussman, M., Orchard, P., Marx, J.C., Pyeritz, R.E., and Brenner, M.K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5, 309, 1999.
24. Lennon, D.P., and Caplan, A.I. Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34, 1604, 2006.
25. Selvaggi, T.A., Walker, R.E., and Fleisher, T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89, 776, 1997.
26. Mackensen, A., Drager, R., Schlesier, M., Mertelsmann, R., and Lindemann, A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49, 152, 2000.
27. Tuschong, L., Soenen, S.L., Blaese, R.M., Candotti, F., and Muul, L.M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 13, 1605, 2002.
28. Sakamoto, N., Tsuji, K., Muul, L.M., Lawler, A.M., Petricoin, E.F., Candotti, F., Metcalf, J.A., Tavel, J.A., Lane, H.C., Urba, W.J., Fox, B.A., Varki, A., Lunney, J.K., and Rosenberg, A.S. Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 110, 501, 2007.
29. Sundin, M., Ringden, O., Sundberg, B., Nava, S., Gotherstromm, C., and Le Blanc, K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92, 1208, 2007.
30. Kuznetsov, S.A., Friedenstein, A.J., and Robey, P.G. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97, 561, 1997.
31. Kuznetsov, S.A., Mankani, M.H., and Robey, P.G. Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70, 1780, 2000.
32. Spees, J.L., Gregory, C.A., Singh, H., Tucker, H.A., Peister, A., Lynch, P.J., Hsu, S.C., Smith, J., and Prockop, D.J. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9, 747, 2004.
33. Doucet, C., Ernou, I., Zhang, Y.Z., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005.
34. Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Stadelmeyer, E., Drexler, C., Lanzer, G., Linkesch, W., and Strunk, D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436, 2007.
35. Lange, C., Cakiroglu, F., Spiess, A.N., Cappallo-Obermann, H., Dierlamm, J., and Zander, A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213, 18, 2007.
36. Reinisch, A., Bartmann, C., Rohde, E., Schallmoser, K., Bjelic-Radisic, V., Lanzer, G., Linkesch, W., and Strunk, D. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2, 371, 2007.
37. Mannello, F., and Tonti, G.A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serumreplacement nonconditionedmedium, or ad hoc formula? All that glitters is not gold! Stem Cells 25, 1603, 2007.
38. Rohde, E., Schallmoser, K., Bartmann, C., Reinisch, A., and Strunk, D. GMP-compliant propagation of human multipotent mesenchymal stromal cells. In: Gad, S.C., ed. Pharmaceutical Manufacturing Handbook: Regulations and Quality. Hoboken, NJ: John Wiley & Sons, Inc., 2008, pp. 97-115.
39. Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices. 1987, Sections I-IV: http://www.fda.gov/cber/ gdlns/lal.pdf.
40. Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., Cho, E.K., Dallaire, S., Freeman, J.L., Gonzalez, J.R., Gratacos, M., Huang, J., Kalaitzopoulos, D., Komura, D., MacDonald, J.R., Marshall, C.R., Mei, R., Montgomery, L., Nishimura, K., Okamura, K., Shen, F., Somerville, M.J., Tchinda, J., Valsesia, A., Woodwark, C., Yang, F., Zhang, J., Zerjal, T., Armengol, L., Conrad, D.F., Estivill, X., Tyler-Smith, C., Carter, N.P., Aburatani, H., Lee, C., Jones, K.W., Scherer, S.W., and Hurles, M.E. Global variation in copy number in the human genome. Nature 444, 444, 2006.
41. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
42. Colter, D.C., Class, R., DiGirolamo, C.M., and Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97, 3213, 2000.
43. Gregory, C.A., Singh, H., Perry, A.S., and Prockop, D.J. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278, 28067, 2003.
44. De Boer, J., Wang, H.J., and van Blitterswijk, C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10, 393, 2004.
45. Rubio, D., Garcia-Castro, J., Martin, M.C., de la Fuente, R., Cigudosa, J.C., Lloyd, A.C., and Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res 65, 3035, 2005.
46. Miura, M., Miura, Y., Padilla-Nash, H.M., Molinolo, A.A., Fu, B., Patel, V., Seo, B.M., Sonoyama, W., Zheng, J.J., Baker, C.C., Chen, W., Ried, T., and Shi, S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095, 2006.
47. Tolar, J., Nauta, A.J., Osborn, M.J., Panoskaltsis Mortari, A., McElmurry, R.T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T.M., Westendorf, J.J., McIvor, R.S., Hogendoorn, P.C., Szuhai, K., Oseth, L., Hirsch, B., Yant, S.R., Kay, M.A., Peister, A., Prockop, D.J., Fibbe, W.E., and Blazar, B.R. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25, 371, 2007.
48. Rubio, D., Garcia, S., Paz, M.F., de la Cueva, T., Lopez-Fernandez, L.A., Lloyd, A.C., Garcia-Castro, J., and Bernad, A. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS ONE 3, e1398, 2008.
49. Bernardo, M.E., Avanzini, M.A., Perotti, C., Cometa, A.M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., de Silvestri, A., Amendola, G., Zuffardi, O., Maccario, R., and Locatelli, F. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211, 121, 2007.
50. Lataillade, J.J., Doucet, C., Bey, E., Carsin, H., Huet, C., Clairand, I., Bottollier-Depois, J.F., Chapel, A., Ernou, I., Gourven, M., Boutin, L., Hayden, A., Carcamo, C., Buglova, E., Joussemet, M., de Revel, T., and Gourmelon, P. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2, 785, 2007.
51. Bernardo, M.E., Zaffaroni, N., Novara, F., Cometa, A.M., Avanzini, M.A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M.G., Zuffardi, O., and Locatelli, F. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67, 9142, 2007.
52. Ludwig, T.E., Bergendahl, V., Levenstein, M.E., Yu, J., Probasco, M.D., and Thomson, J.A. Feeder-independent culture of human embryonic stem cells. Nat Methods 3, 637, 2006.